Pfizer Inc Earnings
The next earnings date for Pfizer Inc is August 4, 2026.
They are scheduled to announce earnings before the market opens that day.
Analyst Estimates of Pfizer Inc Earnings
| 08/04/2026 | $0.68 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Pfizer Inc Earnings: Historical
| 05/05/2026 | Before Market | $0.75 | 4.17% |
| 02/03/2026 | Before Market | $0.66 | 15.79% |
| 11/04/2025 | Before Market | $0.87 | 38.10% |
| 08/05/2025 | Before Market | $0.78 | 36.84% |
| 04/29/2025 | Before Market | $0.92 | 37.31% |
| 02/04/2025 | Before Market | $0.63 | 36.96% |
| 10/29/2024 | Before Market | $1.06 | 73.77% |
| 07/30/2024 | Before Market | $0.60 | 30.43% |
| 05/01/2024 | Before Market | $0.82 | 60.78% |
| 01/30/2024 | Before Market | $0.10 | 155.56% |
More About Pfizer Inc
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
“Pfizer Inc Earnings” Can Refer to the Pfizer Inc Earnings Date
Some people say “Pfizer Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Pfizer Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Pfizer Inc Stock on the Earnings Date
If you own Pfizer Inc stock (PFE) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Pfizer Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Pfizer Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Owning Pfizer Inc Options on the Earnings Date
If you own Pfizer Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
In addition, the extrinsic values of Pfizer Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Pfizer Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.
This makes sense considering that prices are often more volatile on earnings dates for Pfizer Inc. That potential volatility is a key factor that affects the premium cost of owning options.
Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Pfizer Inc options often go down. This is sometimes referred to as volatility crush.
Learning More Pfizer Inc Earnings
You can contact us any time if you would like to ask questions about Pfizer Inc earnings or anything else related to the stock market.